We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cellular Biomedicine Group Inc | NASDAQ:CBMG | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 19.74 | 19.74 | 19.80 | 0 | 01:00:00 |
1. Name and Address of Reporting Person * Belmont Terry | 2. Issuer Name and Ticker or Trading Symbol Cellular Biomedicine Group, Inc. [ CBMG ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Non-Qualified Stock Option | $15.62 | 2/19/2021 | D | 3000 | 11/7/2015 | 11/7/2024 | Common Stock | 3000 | (1) | 0 | D | ||||
Non-Qualified Stock Option | $12.94 | 2/19/2021 | D | 4000 | 12/9/2015 | 12/9/2024 | Common Stock | 4000 | (1) | 0 | D | ||||
Non-Qualified Stock Option | $20.00 | 2/19/2021 (2) | D | 8761 | 11/8/2016 | 2/9/2023 | Common Stock | 8761 | (3) | 0 | D | ||||
Non-Qualified Stock Option | $13.35 | 2/19/2021 (4) | D | 11895 | 6/2/2017 | 12/28/2026 | Common Stock | 11895 | (1) | 0 | D | ||||
Non-Qualified Stock Option | $10.80 | 2/19/2021 (5) | D | 14648 | 4/28/2018 | 4/28/2027 | Common Stock | 14648 | (1) | 0 | D | ||||
Non-Qualified Stock Option | $19.71 | 2/19/2021 | D | 8765 | 4/26/2019 | 5/18/2028 | Common Stock | 8765 | (1) | 0 | D | ||||
Non-Qualified Stock Option | $17.00 | 2/19/2021 (6) | D | 6944 | 4/24/2020 | 5/15/2029 | Common Stock | 6944 | (1) | 0 | D | ||||
Non-Qualified Stock Option | $14.68 (7) | 2/19/2021 | D | 6348 | 4/23/2021 (8) | 4/25/2030 | Common Stock | 6348 | (1) | 0 | D |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Belmont Terry C/O CELLULAR BIOMEDICINE GROUP, INC. 9605 MEDICAL CENTER DRIVE, SUITE 100 ROCKVILLE, MD 20850 | X |
Signatures | ||
/s/ Terry Belmont | 2/19/2021 | |
**Signature of Reporting Person | Date |
1 Year Cellular Biomedicine Chart |
1 Month Cellular Biomedicine Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions